{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:58:26Z","timestamp":1778029106571,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"New Zealand Society of Gastroenterology","award":["N.A."],"award-info":[{"award-number":["N.A."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12072-018-9902-x","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T08:08:02Z","timestamp":1540886882000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identifying barriers to treatment of HCV in the primary care setting"],"prefix":"10.1007","volume":"13","author":[{"given":"Steve","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Aluzaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Taar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"9902_CR1","unstructured":"Global health sector strategy on viral hepatitis 2016\u20132021. WHO. 2016. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/246177\/1\/WHO-HIV-2016.06-eng.pdf?ua=1\n                    \n                  . Accessed 18 Dec 2017."},{"key":"9902_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D., Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011;17:107\u201315.","journal-title":"Clin Microbiol Infect"},{"key":"9902_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293.","journal-title":"Ann Intern Med"},{"key":"9902_CR4","unstructured":"Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Updated version, April 2016. Geneva: World Health Organization. 2016. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/205035\/1\/9789241549615_eng.pdf?ua=1\n                    \n                  . Accessed Apr 2018."},{"key":"9902_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7326\/M17-0118","volume":"167","author":"S Kattakuzhy","year":"2017","unstructured":"Kattakuzhy S, Gross C, Emmanuel B, Teferi G, Jenkins V, Silk R, et al., Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: a nonrandomized clinical trial. Ann Intern Med 2017;167(5):311\u20138.","journal-title":"Ann Intern Med"},{"key":"9902_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jgh.12863","volume":"30","author":"W Cheng","year":"2015","unstructured":"Cheng W, Nazareth S, Flexman JP. Statewide hepatitis C model of care for rural and remote regions. J Gastroenterol Hepatol 2015;30:1\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"280\u20138","key":"9902_CR7","first-page":"e1","volume":"8","author":"AG Singal","year":"2010","unstructured":"Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol 2010;8(280\u20138):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"9902_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","volume":"147","author":"BJ Veldt","year":"2007","unstructured":"Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, et al., Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007;147(10):677\u201384.","journal-title":"Ann Intern Med"},{"key":"9902_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.1365-2893.2003.00481.x","volume":"11","author":"A Kasahara","year":"2004","unstructured":"Kasahara A, Tanaka H, Okanoue T, et al. Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death. J Viral Hepatitis 2004;11:148\u201356.","journal-title":"J Viral Hepatitis"},{"key":"9902_CR10","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ Meer van Der","year":"2012","unstructured":"van Der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012;308:2584.","journal-title":"JAMA"},{"key":"9902_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/jac\/dkq157","volume":"65","author":"ML Volk","year":"2010","unstructured":"Volk ML. Antiviral therapy for hepatitis C: why are so few patients being treated? J Antimicrob Chemother 2010;65:1327\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"9902_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1071\/PY10069","volume":"17","author":"SM Lambert","year":"2011","unstructured":"Lambert SM, Page AN, Wittmann J, Hayllar JS, Ferndale CW, Bain TM, et al., General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting. Aust J Prim Health 2011;17(3):282\u20137.","journal-title":"Aust J Prim Health"},{"key":"9902_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705.","journal-title":"Ann Intern Med"},{"key":"9902_CR14","doi-asserted-by":"publisher","first-page":"S257\u2013S","DOI":"10.1016\/S0016-5085(14)60905-7","volume":"146","author":"S Judd","year":"2014","unstructured":"Judd S, Liubakka A, Antaki F. Are primary care providers\u2019 (PCPS) beliefs and attitudes impacting patients\u2019 perceptions of chronic hepatitis C virus (HCV) and treatment decisions? Gastroenterology 2014;146:S257\u2013S.","journal-title":"Gastroenterology"},{"key":"9902_CR15","unstructured":"R: a language and environment for statistical computing. R Foundation for statistical computing. 2008. At \n                    http:\/\/www.R-project.org\n                    \n                  . Accessed 10 Apr 2018."},{"key":"9902_CR16","unstructured":"The Royal New Zealand College of General Practitioners, Annual Report 2017.\u00a0 At \n                    https:\/\/oldgp16.mzcgp.org.nz\/assets\/New-website\/About-us\/Governance-and-Management\/Governance-minutes\/2017-Annual-Reportweb-versionfinal.pdf\n                    \n                  . Accessed 13 June 2018."},{"key":"9902_CR17","unstructured":"Booker C, Harris R, Leitch S, Lloyd H, Simonsen K, Willis S. The treatment of hepatitis C has changed. Best Practice Journal 2016 (77 SE), p. 15."},{"key":"9902_CR18","unstructured":"NZ Society of Gastroenterology HCV Treatment Guidelines. New Zealand Society of Gastroenterology. 2016. At \n                    https:\/\/nzsg.org.nz\/assets\/Uploads\/NZSG-Hepatitis-C-Guidance-November-UPDATE.pdf\n                    \n                  . Accessed Sep 2018."},{"key":"9902_CR19","unstructured":"Hepatitis C Learning Programme. Ministry of Health. At \n                    https:\/\/learnonline.health.nz\/course\/category.php?id=9\n                    \n                  . Accessed 17 Sep 2018."},{"key":"9902_CR20","unstructured":"Curing Hepatitis C in primary care. The Goodfellow Unit. 2017. At \n                    www.goodfellowunit.org\/events\/curing-hepatitis-c\n                    \n                  . Accessed 17 Sep 2018."},{"key":"9902_CR21","first-page":"309","volume":"63","author":"LJ Stockman","year":"2014","unstructured":"Stockman LJ, Guilfoye SM, Benoit AL, Vergeront JM, Davis JP. Rapid hepatitis C testing among persons at increased risk for infection\u2014Wisconsin, 2012\u20132013. MMWR Morb Mortal Wkly Rep 2014;63:309\u201311.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"9902_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"Z-H Lin","year":"2011","unstructured":"Lin Z-H, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al., Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011;53(3):726\u201336.","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-018-9902-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9902-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T17:59:01Z","timestamp":1572458341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-018-9902-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["9902"],"URL":"https:\/\/doi.org\/10.1007\/s12072-018-9902-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Steve Johnson, Kristina Aluzaite, Anna Taar, and Michael Schultz declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the University of Otago Human Ethics Committee (reference number D16\/400).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}